Related Experiment Video
Updated: Jul 29, 2025
Strategies for Study of Neuroprotection from Cold-preconditioning
Published on: September 2, 2010
Recent advances to Neuroprotection: repurposing drugs against neuroinflammatory disorders
Wishah Bilal1, Muhammad Babar Khawar2, Ali Afzal3
1Institute of Zoology, University of the Punjab, Lahore, Pakistan.
Abstract:
Cell death is a natural mechanism for biological clearance for the maintenance of homeostasis in a dynamic microenvironment of the central nervous system. Stress and various factors can lead to imbalance between cellular genesis and cell death leading to dysfunctionality and a number of neuropathological disorders. Drug repurposing can help bypass development time and cost. A complete understanding of drug actions and neuroinflammatory pathways can lead to effective control of neurodegenerative disorders. This review covers recent advances in various neuroinflammatory pathways understanding, biomarkers, and drug repurposing for neuroprotection.
Insights
Cell death is vital for central nervous system homeostasis. Understanding neuroinflammation and repurposing drugs offers new strategies for treating neurodegenerative disorders.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Cell death is a natural process crucial for maintaining central nervous system (CNS) homeostasis.
- Imbalances in cell genesis and death contribute to neuropathological disorders.
- Drug repurposing presents a cost-effective strategy for developing new treatments.
Purpose of the Study:
- To review recent advancements in understanding neuroinflammatory pathways.
- To explore novel biomarkers for neurodegenerative diseases.
- To discuss drug repurposing strategies for neuroprotection.
Main Methods:
- Literature review of recent research on neuroinflammation.
- Analysis of studies on biomarkers for CNS disorders.
- Examination of drug repurposing case studies in neuroprotection.
Main Results:
- Key neuroinflammatory pathways and their roles in disease are elucidated.
- Emerging biomarkers show potential for early diagnosis and monitoring.
- Successful examples of repurposed drugs demonstrate therapeutic efficacy.
Conclusions:
- A comprehensive understanding of neuroinflammation is critical for developing effective therapies.
- Biomarkers are essential for personalized treatment approaches.
- Drug repurposing holds significant promise for accelerating the development of neuroprotective agents.
More Related Videos
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
10:32Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions
Published on: January 18, 2016
